Results for Primary Bypass Versus Primary Angioplasty/stent for Intermittent Claudication Due to Superficial Femoral Artery Occlusive Disease

Overview

Journal J Vasc Surg

Publisher Elsevier

Specialties Cardiology & Vascular Diseases
General Surgery

Date 2012 Feb 4

PMID 22301210

Citations 30

Authors

Jeffrey J Siracuse

Kristina A Giles

Frank B Pomposelli

Allen D Hamdan

Mark C Wyers

Elliot L Chaikof

April E Nedeau

Marc L Schermerhorn

Affiliations

Soon will be listed here.

Abstract

Background: Percutaneous transluminal angioplasty ± stent (PTA/S) and surgical bypass are both accepted treatments for claudication due to superficial femoral artery (SFA) occlusive disease. However, long-term results comparing these modalities for primary intervention in patients who have had no prior intervention have not been reported. We report our results with 3-year follow-up.

Methods: We reviewed all lower extremity bypass procedures at Beth Israel Deaconess Medical Center from 2001 through 2009 and all PTA/S performed from 2005 through 2009 for claudication. We excluded all limb salvage procedures and included only those that were undergoing their first intervention for claudication due to SFA disease. We recorded patient demographics, comorbidities, perioperative medications, TASC classification, and runoff. Outcomes included complications, restenosis, symptom recurrence, reinterventions, major amputation, and mortality.

Results: We identified 113 bypass grafts and 105 PTA/S of femoral-popliteal lesions without prior interventions. Bypasses were above the knee in 62% (45% vein) and below the knee in 38% (100% vein). Mean age was 63 (bypass) versus 69 (PTA/S; P < .01). Mean length of stay (LOS) was 3.9 versus 1.2 days (P < .01). Bypass grafts were used less for TASC A (17% vs 40%; P < .01) and more for TASC C (36% vs 11%; P < .01) and TASC D (13% vs 3%; P < .01) lesions. There were no differences in perioperative (2% vs 0%; not significant [NS]) or 3-year mortality (9% vs 8%; NS). Wound infection was higher with bypass (16% vs 0%; P < .01). None involved grafts. Bypass showed improved freedom from restenosis (73% vs 42% at 3 years; hazard ratio [HR], 0.4; 95% confidence interval [CI], .23-.71), symptom recurrence (70% and 36% at 3 years; HR, 0.37; 95% CI, .2-.56), and freedom from symptoms at last follow-up (83% vs 49%; HR, 0.18; 95% CI, .08-.40). There was no difference in freedom from reintervention (77% vs 66% at 3 years; NS). Multivariable analysis of all patients showed that restenosis was predicted by PTA/S (HR, 2.5; 95% CI, 1.4-4.4) and TASC D (HR, 3.7; 95% CI, 3.5-9) lesions. Recurrence of symptoms was similarly predicted by PTA/S (HR, 3.0; 95% CI, 1.8-5) and TASC D lesions (HR, 3.1; 95% CI, 1.4-7). Statin use postoperatively was predictive of patency (HR, 0.6; 95% CI, .35-.97) and freedom from recurrent symptoms (HR, 0.6; 95% CI, .36-.93).

Conclusions: Surgical bypass for the primary treatment of claudication showed improved freedom from restenosis and symptom relief despite treatment of more extensive disease, but was associated with increased LOS and wound infection. Statins improved freedom from restenosis and symptom recurrence overall.

Citing Articles

Usefulness of Blood Flow Measurement Device Using Bioelectrical Impedance Plethysmography in Lower-Extremity Artery Disease.

Horinaka S, Sakuma M, Yonezawa Y, Watahiki M, Higano C, Toyoda S Circ Rep. 2025; 7(2):113-121.

PMID: 39931710 PMC: 11807697. DOI: 10.1253/circrep.CR-24-0046.

Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication.

Jarosinski M, Hafeez M, Sridharan N, Andraska E, Meyer J, Khamzina Y J Vasc Surg. 2024; 81(1):200-209.e3.

PMID: 39208918 PMC: 11684783. DOI: 10.1016/j.jvs.2024.08.033.

Retrograde Peroneal Artery Approach to Treat Infra-Inguinal Arterial Chronic Total Occlusions: A Multicentre Experience and Technical Considerations.

Patrone L, Falcone G, Coscas R, Lichaa H, Antaredja M, Fanelli F J Clin Med. 2024; 13(10).

PMID: 38792312 PMC: 11121828. DOI: 10.3390/jcm13102770.

Alternative Occlusion Method with Handmade Umbrella in Renal Artery Perforation.

Torun A, Bildirici U Acta Cardiol Sin. 2023; 39(4):654-657.

PMID: 37456946 PMC: 10346050. DOI: 10.6515/ACS.202307_39(4).20230416A.

Female Sex is Associated with More Reinterventions after Endovascular and Open Interventions for Intermittent Claudication.

Levin S, Farber A, King E, Giles K, Eslami M, Patel V Ann Vasc Surg. 2022; 86:85-93.

PMID: 35809741 PMC: 9846811. DOI: 10.1016/j.avsg.2022.05.036.

References

Matsi P, Manninen H, Soder H, Mustonen P, Kouri J . Percutaneous transluminal angioplasty in femoral artery occlusions: primary and long-term results in 107 claudicant patients using femoral and popliteal catheterization techniques. Clin Radiol. 1995; 50(4):237-44. DOI: 10.1016/s0009-9260(05)83478-6. View

Schermerhorn M, Cronenwett J, Baldwin J . Open surgical repair versus endovascular therapy for chronic lower-extremity occlusive disease. Annu Rev Med. 2002; 54:269-83. DOI: 10.1146/annurev.med.54.101601.152509. View

Wolf G, Wilson S, Cross A, DEUPREE R, Stason W . Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol. 1993; 4(5):639-48. DOI: 10.1016/s1051-0443(93)71939-9. View

Dormandy J, Rutherford R . Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31(1 Pt 2):S1-S296. View

Abbruzzese T, Havens J, Belkin M, Donaldson M, Whittemore A, Liao J . Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004; 39(6):1178-85. PMC: 2643376. DOI: 10.1016/j.jvs.2003.12.027. View

Giles K, Pomposelli F, Spence T, Hamdan A, Blattman S, Panossian H . Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008; 48(1):128-36. DOI: 10.1016/j.jvs.2008.02.027. View

Byrne J, Darling 3rd R, Chang B, Paty P, Kreienberg P, Lloyd W . Infrainguinal arterial reconstruction for claudication: is it worth the risk? An analysis of 409 procedures. J Vasc Surg. 1999; 29(2):259-67; discussion 267-9. DOI: 10.1016/s0741-5214(99)70379-4. View

Jamsen T, Manninen H, Tulla H, Jaakkola P, Matsi P . Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment. J Vasc Surg. 2003; 37(4):808-15. DOI: 10.1067/mva.2003.148. View

van der Zaag E, Legemate D, Prins M, Reekers J, Jacobs M . Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg. 2004; 28(2):132-7. DOI: 10.1016/j.ejvs.2004.04.003. View

10.

Kalbaugh C, Taylor S, Blackhurst D, Dellinger M, Trent E, Youkey J . One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg. 2006; 44(2):296-302. DOI: 10.1016/j.jvs.2006.04.045. View

11.

Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten T . Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg. 1991; 5(5):517-22. DOI: 10.1016/s0950-821x(05)80338-x. View

12.

Plenge J, Hernandez T, Weil K, Poirier P, Grunwald G, Marcovina S . Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002; 106(12):1447-52. DOI: 10.1161/01.cir.0000029743.68247.31. View

13.

Stewart K, Hiatt W, Regensteiner J, Hirsch A . Exercise training for claudication. N Engl J Med. 2002; 347(24):1941-51. DOI: 10.1056/NEJMra021135. View

14.

Schanzer A, Hevelone N, Owens C, Beckman J, Belkin M, Conte M . Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg. 2008; 47(4):774-781. DOI: 10.1016/j.jvs.2007.11.056. View

15.

Fujioka K, Esato K, Zempo N, Katoh T, Fujimura Y, Yoshimura K . Arterial reconstruction: justified for patients with intermittent claudication?. World J Surg. 1998; 22(10):1039-42. DOI: 10.1007/s002689900513. View

16.

Mcquade K, Gable D, Pearl G, Theune B, Black S . Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2010; 52(3):584-90. DOI: 10.1016/j.jvs.2010.03.071. View

17.

Scott E, Biuckians A, Light R, Scibelli C, Milner T, Meier 3rd G . Subintimal angioplasty for the treatment of claudication and critical limb ischemia: 3-year results. J Vasc Surg. 2007; 46(5):959-64. DOI: 10.1016/j.jvs.2007.06.031. View

18.

Otsuka F, Hibi K, Kusama I, Endo M, Kosuge M, Iwahashi N . Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction. Atherosclerosis. 2010; 213(2):505-11. DOI: 10.1016/j.atherosclerosis.2010.09.005. View

19.

Rabellino M, Zander T, Baldi S, Garcia Nielsen L, Aragon-Sanchez F, Zerolo I . Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment. Catheter Cardiovasc Interv. 2009; 73(5):701-5. DOI: 10.1002/ccd.21971. View

20.

Joels C, York J, Kalbaugh C, Cull D, Langan 3rd E, Taylor S . Surgical implications of early failed endovascular intervention of the superficial femoral artery. J Vasc Surg. 2008; 47(3):562-5. DOI: 10.1016/j.jvs.2007.11.044. View